Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.
Files
Publication date
2009
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Citation
van der Spek, E, Bloem, A C, Lokhorst, H M, van Kessel, B, Bogers - Boer, L H & van de Donk, N W C J 2009, 'Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.', Leukemia Research, vol. 33, no. 1, pp. 100-108.